MXPA06003661A - Sales y polimorfos de un compuesto de indolinona sustituido con pirrol. - Google Patents
Sales y polimorfos de un compuesto de indolinona sustituido con pirrol.Info
- Publication number
- MXPA06003661A MXPA06003661A MXPA06003661A MXPA06003661A MXPA06003661A MX PA06003661 A MXPA06003661 A MX PA06003661A MX PA06003661 A MXPA06003661 A MX PA06003661A MX PA06003661 A MXPA06003661 A MX PA06003661A MX PA06003661 A MXPA06003661 A MX PA06003661A
- Authority
- MX
- Mexico
- Prior art keywords
- salts
- pyrrole
- polymorphs
- indolinone compound
- substituted indolinone
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 3
- -1 pyrrole-substituted indolinone compound Chemical class 0.000 title abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002688 maleic acid derivatives Chemical class 0.000 abstract 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La invencion se refiere a sales no higroscopicas de 5-[(Z)-(5-fluoro- 2-oxo-1, 2-dihidro-3H -indol-3-iliden) metil]-N-[(2S)-2 -hidroxi-3 -morfolin-4 -ilpropil]-2, 4-dimetil-1H -pirrol-3 -carboxamida, que se representa en la formula estructural I (ver formula 1) tales como sales maleato, y a polimorfos cristalinos de estas sales; la invencion se refiere ademas a composiciones farmaceuticas de sales de 5-[(Z)- (5-fluoro-2 -oxo-1, 2-dihidro-3H -indol-3-iliden) metil]-N-[(2S) -2-hidroxi-3 -morfolin-4 -ilpropil]-2, 4-dimetil-1H-pirrol -3-carboxamida, y a metodos para tratar trastornos tales como el cancer empleando dichas composiciones.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50810403P | 2003-10-02 | 2003-10-02 | |
| PCT/IB2004/003070 WO2005033098A1 (en) | 2003-10-02 | 2004-09-20 | Salts and polymorphs of a pyrrole-substituted indolinone compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA06003661A true MXPA06003661A (es) | 2006-06-05 |
Family
ID=34421700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA06003661A MXPA06003661A (es) | 2003-10-02 | 2004-09-20 | Sales y polimorfos de un compuesto de indolinona sustituido con pirrol. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7247627B2 (es) |
| EP (1) | EP1670785B1 (es) |
| JP (1) | JP4933259B2 (es) |
| KR (2) | KR20080007520A (es) |
| CN (1) | CN100432072C (es) |
| AR (1) | AR047762A1 (es) |
| AT (1) | ATE473223T1 (es) |
| AU (1) | AU2004277464B2 (es) |
| BR (1) | BRPI0415022A (es) |
| CA (1) | CA2540639C (es) |
| CY (1) | CY1110771T1 (es) |
| DE (1) | DE602004028028D1 (es) |
| DK (1) | DK1670785T3 (es) |
| ES (1) | ES2348623T3 (es) |
| IL (1) | IL174414A (es) |
| MX (1) | MXPA06003661A (es) |
| NO (1) | NO20061246L (es) |
| NZ (1) | NZ546001A (es) |
| PL (1) | PL1670785T3 (es) |
| PT (1) | PT1670785E (es) |
| RU (1) | RU2319702C2 (es) |
| SI (1) | SI1670785T1 (es) |
| TW (1) | TW200524921A (es) |
| WO (1) | WO2005033098A1 (es) |
| ZA (1) | ZA200602691B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050182122A1 (en) * | 2003-11-20 | 2005-08-18 | Bello Carlo L. | Method of treating abnormal cell growth using indolinone compounds |
| WO2006101692A1 (en) * | 2005-03-23 | 2006-09-28 | Pfizer Products Inc. | Anti-ctla4 antibody and indolinone combination therapy for treatment of cancer |
| CN101267824A (zh) * | 2005-09-20 | 2008-09-17 | 辉瑞产品公司 | 使用酪氨酸激酶抑制剂的治疗剂型和方法 |
| CL2008000070A1 (es) * | 2007-01-17 | 2008-07-25 | Lg Life Sciences Ltd | Monosal del acido maleico (3-[({1-[(2-amino-9h-purin-9-il)metil]ciclopropil}oxi)metil]-8,8-dimetil-3,7-dioxo-2,4,6-trioxa-3 lambda 5-fosfanon-1-il-pivalato; composicion farmaceutica que comprende a dicha monosal; y uso para el tratamiento del virus h |
| JP5531613B2 (ja) * | 2007-04-04 | 2014-06-25 | 大塚化学株式会社 | チタン酸カリウム及びその製造方法並びに摩擦材及び樹脂組成物 |
| CN102159570B (zh) * | 2008-09-17 | 2014-01-15 | 诺瓦提斯公司 | N-[6-(顺式-2,6-二甲基吗啉-4-基)吡啶-3-基]-2-甲基-4’-(三氟甲氧基)[1,1’-联苯]-3-甲酰胺的盐 |
| RU2430361C1 (ru) * | 2010-07-05 | 2011-09-27 | Государственное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет им. В.Ф. Войно-Ясенецкого Министерства здравоохранения и социального развития Российской Федерации" | Способ прогнозирования риска развития диабетической ретинопатии при сахарном диабете типа 2 у якутов |
| WO2012042421A1 (en) | 2010-09-29 | 2012-04-05 | Pfizer Inc. | Method of treating abnormal cell growth |
| US9851313B2 (en) * | 2015-03-03 | 2017-12-26 | Panalytical B.V. | Quantitative X-ray analysis—ratio correction |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1575936A3 (ru) * | 1986-04-10 | 1990-06-30 | Е.И.Дюпон Де Немур Энд Ко.(Фирма) | Способ получени 3,3-дизамещенных индолин-2-ионов или их солей |
| US5534522A (en) * | 1995-06-07 | 1996-07-09 | Warner-Lambert Company | (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent |
| DE19622489A1 (de) * | 1996-06-05 | 1997-12-11 | Hoechst Ag | Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters |
| CO5280092A1 (es) * | 2000-02-15 | 2003-05-30 | Sugen Inc | Indolinas susutituidas con pirroles inhibidoras de proteinquinasas |
| AR042586A1 (es) * | 2001-02-15 | 2005-06-29 | Sugen Inc | 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa |
| EP2332934B1 (en) * | 2001-08-15 | 2017-03-01 | Pharmacia & Upjohn Company LLC | Processes for the preparation of crystals including a malic acid salt of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide. |
| YU67702A (sh) | 2001-09-28 | 2004-12-31 | Pfizer Products Inc. | Postupak za dobijanje alkansulfonil piridina |
| TWI259081B (en) * | 2001-10-26 | 2006-08-01 | Sugen Inc | Treatment of acute myeloid leukemia with indolinone compounds |
| CN1308326C (zh) * | 2002-02-15 | 2007-04-04 | 法马西亚和厄普乔恩公司 | 吲哚满酮衍生物的制备方法 |
| HN2003000272A (es) * | 2002-09-10 | 2008-07-29 | Pharmacia Italia Spa | Formulaciones que comprenden un compuesto de indolinona |
-
2004
- 2004-09-20 BR BRPI0415022-8A patent/BRPI0415022A/pt not_active IP Right Cessation
- 2004-09-20 CA CA2540639A patent/CA2540639C/en not_active Expired - Fee Related
- 2004-09-20 DE DE602004028028T patent/DE602004028028D1/de not_active Expired - Lifetime
- 2004-09-20 JP JP2006530728A patent/JP4933259B2/ja not_active Expired - Fee Related
- 2004-09-20 AT AT04769435T patent/ATE473223T1/de active
- 2004-09-20 CN CNB2004800287364A patent/CN100432072C/zh not_active Expired - Fee Related
- 2004-09-20 NZ NZ546001A patent/NZ546001A/en unknown
- 2004-09-20 AU AU2004277464A patent/AU2004277464B2/en not_active Ceased
- 2004-09-20 PT PT04769435T patent/PT1670785E/pt unknown
- 2004-09-20 PL PL04769435T patent/PL1670785T3/pl unknown
- 2004-09-20 KR KR1020087000428A patent/KR20080007520A/ko not_active Ceased
- 2004-09-20 WO PCT/IB2004/003070 patent/WO2005033098A1/en active Application Filing
- 2004-09-20 ES ES04769435T patent/ES2348623T3/es not_active Expired - Lifetime
- 2004-09-20 KR KR1020067006363A patent/KR20060058728A/ko not_active Ceased
- 2004-09-20 MX MXPA06003661A patent/MXPA06003661A/es active IP Right Grant
- 2004-09-20 DK DK04769435.1T patent/DK1670785T3/da active
- 2004-09-20 SI SI200431486T patent/SI1670785T1/sl unknown
- 2004-09-20 EP EP04769435A patent/EP1670785B1/en not_active Expired - Lifetime
- 2004-09-20 RU RU2006110541/04A patent/RU2319702C2/ru not_active IP Right Cessation
- 2004-09-30 US US10/956,420 patent/US7247627B2/en not_active Expired - Fee Related
- 2004-10-01 AR ARP040103580A patent/AR047762A1/es not_active Application Discontinuation
- 2004-10-01 TW TW093129924A patent/TW200524921A/zh unknown
-
2006
- 2006-03-17 NO NO20061246A patent/NO20061246L/no not_active Application Discontinuation
- 2006-03-20 IL IL174414A patent/IL174414A/en not_active IP Right Cessation
- 2006-03-31 ZA ZA200602691A patent/ZA200602691B/en unknown
-
2010
- 2010-09-03 CY CY20101100810T patent/CY1110771T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110771T1 (el) | Αλατα και πολυμορφα μιας πυρρολο-υποκατεστημενης ινδολινονικης ενωσης | |
| MXPA04004464A (es) | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. | |
| WO2002015662A3 (en) | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists | |
| WO2002017358A3 (en) | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) | |
| NO20075809L (no) | DNA-PK inhibitorer | |
| EE200300403A (et) | N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina | |
| DE602004008098D1 (de) | Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren | |
| NO20054404L (no) | 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon | |
| BG108650A (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
| EP1740581A4 (en) | PYRIDYL DERIVATIVE COMPOUNDS SUBSTITUTED AT POSITIONS 2, 4, 6 USEFUL AS INHIBITORS OF BETA-SECRETASE IN THE TREATMENT OF ALZHEIMER'S DISEASE | |
| WO2002016355A3 (en) | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands | |
| GB0220581D0 (en) | Organic Compound | |
| MY142768A (en) | Gfat inhibitors | |
| CA2825134A1 (en) | Indole derivative, and pharmacologically acceptable salt thereof | |
| MY145632A (en) | 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethylester-methanesulfonate and its use as a medicament | |
| TW200702330A (en) | 3,4,5-Substituted piperidines | |
| NO20062256L (no) | Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner | |
| MXPA05011739A (es) | Derivados de quinuclidina que se enlazan con los receptores muscarinicos m3. | |
| WO2002016356A3 (en) | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) | |
| PT2049480E (pt) | Derivados de 2-arilindole como inibidores da mpges-i | |
| YU89402A (sh) | 5-hloro-3-(4-metansulfonilfenil)-6'-metil-/2,3'/bipiridinil u čistom kristalnom obliku i postupak sinteze | |
| NO20064351L (no) | Caspaseinhibitorer og anvendelser derav | |
| TNSN07006A1 (en) | Novel heterocyclic compounds | |
| MX2007003913A (es) | Alquil-piridinas como inhibidores de 11 beta para diabetes. | |
| RU2372348C2 (ru) | Производные индолилмалеимида в качестве ингибиторов ркс |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |